INDV Stock Analysis: Buy, Sell, or Hold?
INDV - Indivior PLC Ordinary Shares
$34.07
-0.36 (-1.04%)
▼
5d:
+2.05%
30d:
+18.39%
90d:
-2.45%
BUY
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: Apr 30, 2026
TODAY
Smart Money Distribution
INDV is up 5.2% this week, but smart money is buying puts. Top strike: $30 2026-06-18 with 10 OI. Put ratio: 77% View Scanner →
Strength: 5.3/10
Get Alerted When INDV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INDV shows positive signals but monitor for confirmation. Market pricing in 1.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: INDV shows positive signals but monitor for confirmation. Market pricing in 1.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$50.81
Based on 6.9% avg growth
INTRINSIC VALUE TODAY
$31.55
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INDV is currently trading at $34.07, which is considered extended relative to its 30-day fair value range of $29.74 to $33.02. The stock's valuation (Forward PE: 10.1) is in line with its historical norms (10.7). Remarkably, the market is currently pricing in an annual earnings decline of 1.7% over the next few years. This pessimistic expectation contrasts with the company's recent 376.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, INDV is in a strong uptrend. Immediate support is located at $31.23, while resistance sits at $35.34.
Market Sentiment: INDV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.17 (+39.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INDV is in a strong uptrend. Immediate support is located at $31.23, while resistance sits at $35.34.
Market Sentiment: INDV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.17 (+39.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.74 -
$33.02
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.9% below Wall St target ($48.17)
Trading Range Analysis
30-Day Trading Range
$29.74 -
$33.02
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$31.23
Resistance Level
$35.34
Current Trend
Strong Uptrend
Technical data as of
Apr 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.11
Wall Street Target
$48.17
(+39.9%)
Revenue Growth (YoY)
19.7%
Earnings Growth (YoY)
376.2%
Profit Margin
17.0%
Valuation Discount vs History
-1.7% cheaper
PE vs Historical
10.1 vs 10.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.7%
(market-implied from PE analysis)
1-Year Target
$33.84
(-2%)
2-Year Target
$33.27
(-3%)
3-Year Target
$32.70
(-5%)
3-Yr Target (if PE normalizes)
(PE: 10→11)
$34.61
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 9.8%)
$93.00
(+170%)
Base:
(SPY PE: 10.1, Growth: 9.8%)
$45.63
(+33%)
Bear:
(PE: 8.6, Growth: 9.8%)
$38.78
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 20.92 | Current EPS (TTM): $1.64
Bull Case
$75.48
(+119%)
Analyst growth 100.0%, PE expands to 23.0
Base Case
$68.62
(+99%)
Market implied 100.0%, PE stable at 20.9
Bear Case
$23.33
(-32%)
Severe decline -20.0%, PE contracts to 17.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.1 to 10.7
Stabilization Target:
$36.43
(+5.8%)
PE Expansion Potential:
+5.8%
Share & Embed Analysis
Last updated: April 29, 2026 1:29 PM ET
Data refreshes hourly during market hours. Next update: 2:29 PM
Data refreshes hourly during market hours. Next update: 2:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INDV showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Barbara Ryan
BUY
31 shares
2026-03-09
Stuart A Kingsley
BUY
940 shares
2026-03-06
Barbara Ryan
BUY
775 shares
2026-01-05
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$186 | 60 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$150 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$94 | 58 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
Advanced INDV Option Strategies
Professional options setups generated by AI based on today's INDV price and gamma walls.
